Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Current Neuropharmacology
|
May 17, 2018
P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke
Hengli Zhao, Yujie Chen, Hua Feng
Central-European Journal of Immunology
|
May 19, 2023
HMBOX1, a member of the homeobox family: current research progress
Yu Jiang, Hongli Mu, Hengli Zhao
Oncology Reports
|
July 18, 2018
Homeobox containing 1 inhibits liver cancer progression by promoting autophagy as well as inhibiting stemness and immune escape
Hengli Zhao, Huifeng Jia, Qiuju Han, et al.
Chemical Science
|
December 22, 2022
Cutting-edge molecular modelling to unveil new microscopic insights into the guest-controlled flexibility of metal-organic frameworks
Hengli Zhao, Camille Pelgrin-Morvan, Guillaume Maurin, et al.
Die Pharmazie
|
December 11, 2020
Pharmacokinetics and tolerability of intravenous posaconazole in healthy Chinese volunteers: a randomized, open-label and single-dose study
Wei Ji, Hengli Zhao, Shaomei Yang, et al.
Molecular Immunology
|
July 23, 2018
HMBOX1 in hepatocytes attenuates LPS/D-GalN-induced liver injury by inhibiting macrophage infiltration and activation
Hengli Zhao, Qiuju Han, Nan Lu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 26, 2022
Prediction of janagliflozin pharmacokinetics in type 2 diabetes mellitus patients with liver cirrhosis or renal impairment using a physiologically based pharmacokinetic model
Hengli Zhao, Yilin Wei, Kun He, et al.
Clinical Pharmacology in Drug Development
|
March 3, 2023
Effect of Dietary Intake on the Pharmacokinetics of the Multitargeted Receptor Tyrosine Kinase Inhibitor Famitinib: Results From a Phase 1 Study in Healthy Chinese Participants
Xiaoran Zhang, Gexin Shi, Shaorong Li, et al.
Frontiers in Cell and Developmental Biology
|
February 7, 2022
Heme in Cardiovascular Diseases: A Ubiquitous Dangerous Molecule Worthy of Vigilance
Yuyang Guo, Hengli Zhao, Zhibin Lin, et al.
Discover Oncology
|
August 5, 2025
A ferroptosis-related risk model for non-coding RNA AC002331.1 in colon cancer: construction via competing endogenous RNA network analysis
Jiahui Liu, Chenning Zhang, Bao Ma, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Current Neuropharmacology
|
May 17, 2018
P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke
Hengli Zhao, Yujie Chen, Hua Feng
Central-European Journal of Immunology
|
May 19, 2023
HMBOX1, a member of the homeobox family: current research progress
Yu Jiang, Hongli Mu, Hengli Zhao
Oncology Reports
|
July 18, 2018
Homeobox containing 1 inhibits liver cancer progression by promoting autophagy as well as inhibiting stemness and immune escape
Hengli Zhao, Huifeng Jia, Qiuju Han, et al.
Chemical Science
|
December 22, 2022
Cutting-edge molecular modelling to unveil new microscopic insights into the guest-controlled flexibility of metal-organic frameworks
Hengli Zhao, Camille Pelgrin-Morvan, Guillaume Maurin, et al.
Die Pharmazie
|
December 11, 2020
Pharmacokinetics and tolerability of intravenous posaconazole in healthy Chinese volunteers: a randomized, open-label and single-dose study
Wei Ji, Hengli Zhao, Shaomei Yang, et al.
Molecular Immunology
|
July 23, 2018
HMBOX1 in hepatocytes attenuates LPS/D-GalN-induced liver injury by inhibiting macrophage infiltration and activation
Hengli Zhao, Qiuju Han, Nan Lu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 26, 2022
Prediction of janagliflozin pharmacokinetics in type 2 diabetes mellitus patients with liver cirrhosis or renal impairment using a physiologically based pharmacokinetic model
Hengli Zhao, Yilin Wei, Kun He, et al.
Clinical Pharmacology in Drug Development
|
March 3, 2023
Effect of Dietary Intake on the Pharmacokinetics of the Multitargeted Receptor Tyrosine Kinase Inhibitor Famitinib: Results From a Phase 1 Study in Healthy Chinese Participants
Xiaoran Zhang, Gexin Shi, Shaorong Li, et al.
Frontiers in Cell and Developmental Biology
|
February 7, 2022
Heme in Cardiovascular Diseases: A Ubiquitous Dangerous Molecule Worthy of Vigilance
Yuyang Guo, Hengli Zhao, Zhibin Lin, et al.
Discover Oncology
|
August 5, 2025
A ferroptosis-related risk model for non-coding RNA AC002331.1 in colon cancer: construction via competing endogenous RNA network analysis
Jiahui Liu, Chenning Zhang, Bao Ma, et al.
Page
of 6